DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.

DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Abstract Text:

DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: International journal of cancer. Journal internati

VOLUME: 123

Page Numbers: 535-42

Journal Abbreviation: Int. J. Cancer

ISSN: 1097-0215

DAY: 1

MONTH: Aug

YEAR: 2008

DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 42124

DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.

AFFILIATION:

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int J Cancer

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines Related Publications

• A dioxin-responsive enhancer 3' of the human CYP1A2 gene.
• Basal cell carcinoma with pulmonary and lymph node metastasis causing death.
• COD and BOD removal from domestic wastewater generated in decentralised sectors.
• COMT polymorphisms affecting protein expression are risk factors for endometrial cancer.
• CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility.
• Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer.
• DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.
• Effect of delignification pretreatment and selective enrichment on methane production from cattle waste.
• Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer.
• Erythematous pedunculated papule on a 29-year-old man--quiz case.
• GGC and StuI polymorphism on the androgen receptor gene in endometrial cancer patients.
• Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function.
• Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification.
• Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells.
• Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity.
• MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
• MicroRNA-373 induces expression of genes with complementary promoter sequences.
• Mismatch Repair Gene MSH3 Polymorphism is Associated With the Risk of Sporadic Prostate Cancer.
• Polymorphisms of DNA repair genes are risk factors for prostate cancer.
• Polymorphisms of catechol-O-methyltransferase in men with renal cell cancer.
• Synthesis of a phenylalanine-rich peptide as potential anthelmintic and cytotoxic agent.
• Total synthesis and biological potential of psammosilenin a.
• Transformation of Progesterone by Traemetes hispida.
• Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.